Diabetes Clinical Trial
— WSSOfficial title:
Work-site Intervention Study to Prevent Diabetes in Nepal
Verified date | November 2019 |
Source | B.P. Koirala Institute of Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The burden of non-communicable disease is on the rise in low- and middle- income
countries.Cardiovascular disease is the leading cause of morbidity, mortality, and disability
in South Asian regions. Diabetes mellitus is among the top five risk factors for
cardiovascular deaths in the world.
Despite the evidence supporting the use of lifestyle interventions to prevent diabetes and
improve glucose tolerance, their translation in real world has been challenging.
Work-site-based health programs have shown positive impacts on employee health, and have
shown significant improvements in blood glucose levels and HbA1C.
The research will be conducted in 1) Hulas wire Industry and 2) Pragati Textile Industry
Private limited.
Investigator will conduct before-and-after intervention among pre-diabetic employees.In
addition screening will be done to identify the eligible participants.Those who are
pregnant,under diabetic and hypertensive medication will be excluded from the study. All of
the interested adult employees (≥18 years) will be invited for the first screening. All
individuals with HbA1C from 5.7% to 6.4 % will be invited to participate in the study. At
baseline, investigators will administer a standardized questionnaire to record the
characteristics of the participants.Blood samples will be collected and analyzed for HbA1c,
fasting glucose, and lipid profile.
Investigators will have a wait period before implementing any intervention.After completion
of control period,half of the participants will be randomized to receive behavioral
interventions. Behavior intervention will comprise of combination of intensive education
session, group counseling, goal setting and monitoring.Trained nurses will deliver the
sessions once every week for two months and then once every month.All the participants will
receive canteen intervention after behavioral intervention which will comprise of promotion
of healthy foods in the canteen of the study site i.e Improve physical facility ,increase
access to healthy food, Information, Education and communication, changes in food price and
training of canteen staffs Investigators will conduct follow up at 6 months, 12 months, and
18 months and if funds are available at 24 months. During each follow up, the proportion of
unhealthy diet consumption data will be abstracted. In addition, blood samples will be
collected and analyzed for HbA1c, fasting glucose, and lipid profile .This period will serve
as control group.
Status | Active, not recruiting |
Enrollment | 163 |
Est. completion date | February 28, 2021 |
Est. primary completion date | September 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility |
Inclusion Criteria: 1) Pre-diabetic participants (HbA1c 5.7-6.4%) and FBS (>=100 to 125mg/dl) Exclusion Criteria: 1. Diabetic - HbA1c (>=6.5%) and FBS > 126mg/dl 2. HbA1c <5.7% and FBS <100mg/dl 3. Taking hypertension,diabetes medication 4. Pregnancy 5. Temporary workers 6. Age <18 years |
Country | Name | City | State |
---|---|---|---|
Nepal | Hulas Wire industry Private Limited and Pragati Textile Industry Private Limited | Biratnagar | Provinve 1 |
Lead Sponsor | Collaborator |
---|---|
B.P. Koirala Institute of Health Sciences |
Nepal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HbA1C | The primary outcome is absolute change in HbA1c | 24months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |